Autolus Limited
Manufacture of basic pharmaceutical products · London
ActiveUnited KingdomIncorporated 2014Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
09115837- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2014-07-03
- Jurisdiction
- —
- Registered office
- THE MEDIAWORKS, 191 WOOD LANE, LONDON, W12 7FP, ENGLAND
Classification
2 SIC codes2110046460
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
30 matched grantsFAST CAR-T: Faster, Adaptive and Scalable Technologies For CAR-T ManufactureActiveEPSRC · Research and Innovation · 2024-06-30 – 2027-06-29 · with 5 other participants£2,100,849whole project
FAST CAR-T: Faster, Adaptive and Scalable Technologies For CAR-T ManufactureActive
EPSRC · Research and Innovation · 2024-06-30 – 2027-06-29 · with 5 other participants
£2,100,849
whole project
University College LondonleadAutolus LtdNHS Blood And Transplant (Nhsbt)SartoriusSartorius Corporate GmbHScaleReady
Speed-CELL: Accelerating Cell Therapy Release for Rapid Clinical DeploymentInnovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 4 other participants£0awarded
Speed-CELL: Accelerating Cell Therapy Release for Rapid Clinical Deployment
Innovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 4 other participants
£0
awarded
Autolus Limited£0
NHS Blood and Transplant£0
ICF: Chimeric antigen receptor T cells targeting CD123, CD33 and CLL1 for therapy of Acute Myeloid LeukaemiaActiveMRC · Research Grant · 2023-11-01 – 2030-02-28 · with 5 other participants£3,672,874whole project
ICF: Chimeric antigen receptor T cells targeting CD123, CD33 and CLL1 for therapy of Acute Myeloid LeukaemiaActive
MRC · Research Grant · 2023-11-01 – 2030-02-28 · with 5 other participants
£3,672,874
whole project
University College LondonleadAutolus LimitedAutolus LtdChildren's Hospital of PhiladelphiaSt Jude Children's HospitalUniversity Of BirminghamUniversity of Sheffield
ICF: Chimeric antigen receptor T cells targeting CD123, CD33 and CLL1 for therapy of Acute Myeloid LeukaemiaActiveMRC · Research Grant · 2023-11-01 – 2030-02-28 · with 5 other participants£3,672,874whole project
ICF: Chimeric antigen receptor T cells targeting CD123, CD33 and CLL1 for therapy of Acute Myeloid LeukaemiaActive
MRC · Research Grant · 2023-11-01 – 2030-02-28 · with 5 other participants
£3,672,874
whole project
University College LondonleadAutolus LimitedAutolus LtdChildren's Hospital of PhiladelphiaSt Jude Children's HospitalUniversity Of BirminghamUniversity of Sheffield
Northern Alliance ATTCInnovate UK · Centres · 2021-04-01 – 2022-03-31 · with 20 other participants£247,831awarded
Northern Alliance ATTC
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 20 other participants
£247,831
awarded
The Newcastle upon Tyne Hospitals NHS Foundation Trustlead£566,226
Leeds Teaching Hospitals NHS Trust£301,910
Autolus Limited£247,831
University of Edinburgh£232,927
Scottish National Blood Transfusion Service£148,496
Greater Glasgow Health Board£145,285
NHS Blood and Transplant£14,274
NHS Lothian£3,553
Sheffield Teaching Hospitals NHS Foundation Trust£0
University of Glasgow£0
Standard Approach to atMP tissue ColLEction (Sample)Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 7 other participants£30,000awarded
Standard Approach to atMP tissue ColLEction (Sample)
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 7 other participants
£30,000
awarded
The Christie NHS Foundation Trustlead£47,536
Autolus Limited£30,000
Scottish National Blood Transfusion Service£19,146
Northern Alliance ATTCISCF · Centres · 2021-03-31 – 2022-03-30 · with 20 other participants£2,080,814whole project
Northern Alliance ATTC
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 20 other participants
£2,080,814
whole project
The Newcastle Upon Tyne Hospitals NHS Foundation TrustleadAchilles Therapeutics UK LimitedAlcyomics LimitedAutolus LimitedDatatrial LimitedGlobal Life Sciences Solutions Operations UK LtdGreater Glasgow Health BoardHealth Innovation North East And North Cumbria LimitedLeeds Teaching Hospitals NHS TrustNewcastle UniversityNHS Blood And TransplantNHS LothianPhion Therapeutics LtdScottish National Blood Transfusion ServiceSheffield Teaching Hospitals NHS Foundation TrustThermo Electron LimitedTrakcel LimitedUniversity Of EdinburghUniversity Of GlasgowVascversa LtdWorld Courier Management Limited
Standard Approach to atMP tissue ColLEction (Sample)ISCF · Centres · 2021-03-31 – 2022-03-30 · with 7 other participants£463,347whole project
Standard Approach to atMP tissue ColLEction (Sample)
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 7 other participants
£463,347
whole project
The Christie NHS Foundation TrustleadAutolus LimitedCryogatt Systems LimitedGlobal Life Sciences Solutions Operations UK LtdInstil Bio (UK) LimitedOrbsen Therapeutics UK LtdScottish National Blood Transfusion ServiceUniversity Of Birmingham
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral VectorsLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£250,000
awarded
Evaluation of novel protein based disease ameliorating therapeuticsLead
Innovate UK · Feasibility Studies · 2020-05-01 – 2021-02-28
£74,667
awarded
Targeted inhibition of ectoenzymes in the tumour microenvironment to optimise efficacy of chimeric antigen receptors in multiple myelomaMRC · Studentship · 2019-09-30 – 2024-02-24 · with 1 other participant£0whole project
Targeted inhibition of ectoenzymes in the tumour microenvironment to optimise efficacy of chimeric antigen receptors in multiple myeloma
MRC · Studentship · 2019-09-30 – 2024-02-24 · with 1 other participant
£0
whole project
University College LondonleadAutolus Ltd
Development of experimentally-integrated process models for adaptive CAR-T cell therapy manufacturingEPSRC · Studentship · 2019-09-30 – 2022-09-29 · with 2 other participants£0whole project
Development of experimentally-integrated process models for adaptive CAR-T cell therapy manufacturing
EPSRC · Studentship · 2019-09-30 – 2022-09-29 · with 2 other participants
£0
whole project
Digital Delivery of Personalised Advanced TherapiesLead
Innovate UK · Collaborative R&D · 2019-01-01 – 2019-03-31
£1,309,169
awarded
Digital Delivery of Personalised Advanced TherapiesLead
ISCF · Collaborative R&D · 2019-01-01 – 2019-03-31
£1,309,169
whole project
Digital Delivery of Personalised Advanced Therapies
ISCF · Collaborative R&D · 2019-01-01 – 2019-03-31
£1,309,169
whole project
Standard Approach to atMP tissue ColLEction (Sample)Innovate UK · Collaborative R&D · 2018-12-01 – 2022-03-31 · with 9 other participants£349,001awarded
Standard Approach to atMP tissue ColLEction (Sample)
Innovate UK · Collaborative R&D · 2018-12-01 – 2022-03-31 · with 9 other participants
£349,001
awarded
Scottish National Blood Transfusion Service£406,800
Autolus Limited£349,001
The Christie NHS Foundation Trustlead£301,526
NHS Blood and Transplant£249,802
Guy's and St Thomas' NHS Foundation Trust£117,265
The Newcastle upon Tyne Hospitals NHS Foundation Trust£110,193
Manchester University NHS Foundation Trust£15,293
Standard Approach to atMP tissue colLEction (SAMPLE)ISCF · Collaborative R&D · 2018-12-01 – 2022-03-30 · with 9 other participants£2,117,268whole project
Standard Approach to atMP tissue colLEction (SAMPLE)
ISCF · Collaborative R&D · 2018-12-01 – 2022-03-30 · with 9 other participants
£2,117,268
whole project
The Christie NHS Foundation TrustleadAsymptote LimitedAutolus LimitedCellular Therapeutics LtdGuy'S And St Thomas' NHS Foundation TrustManchester University NHS Foundation TrustNHS Blood And TransplantScottish National Blood Transfusion ServiceThe Newcastle Upon Tyne Hospitals NHS Foundation TrustTrakcel Limited
MICA: Optimising combination strategies for chimeric antigen receptor therapy in multiple myelomaMRC · Fellowship · 2018-07-31 – 2023-01-31 · with 4 other participants£809,878whole project
MICA: Optimising combination strategies for chimeric antigen receptor therapy in multiple myeloma
MRC · Fellowship · 2018-07-31 – 2023-01-31 · with 4 other participants
£809,878
whole project
University College LondonleadAutolus LtdFree University of Brussels (VUB)University College LondonUniversity Of Nottingham
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral VectorsLeadISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant£1,225,847whole project
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral VectorsLead
ISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant
£1,225,847
whole project
Autolus LimitedleadUniversity College London
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral VectorsLeadInnovate UK · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant£738,893awarded
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral VectorsLead
Innovate UK · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant
£738,893
awarded
Autolus Limitedlead£738,893
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral VectorsISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant£1,225,847whole project
Design, Transfer and Qualification of a Commercially-Scalable Process for Viral Vectors
ISCF · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant
£1,225,847
whole project
Autolus LimitedleadUniversity College London
Northern Alliance Advanced Therapies Treatment CentreInnovate UK · Collaborative R&D · 2018-03-01 – 2022-03-31 · with 19 other participants£1,287,315awarded
Northern Alliance Advanced Therapies Treatment Centre
Innovate UK · Collaborative R&D · 2018-03-01 – 2022-03-31 · with 19 other participants
£1,287,315
awarded
The Newcastle upon Tyne Hospitals NHS Foundation Trustlead£1,623,506
Autolus Limited£1,287,315
Newcastle University£701,226
Scottish National Blood Transfusion Service£470,116
The Leeds Teaching Hospitals NHS Trust£459,749
Lothian Health Board£308,221
University of Edinburgh£276,428
NHS Blood and Transplant£261,849
NHS Greater Glasgow and Clyde£227,470
Northern Alliance Advanced Therapies Treatment CentreISCF · Collaborative R&D · 2018-03-01 – 2022-03-30 · with 19 other participants£7,544,329whole project
Northern Alliance Advanced Therapies Treatment Centre
ISCF · Collaborative R&D · 2018-03-01 – 2022-03-30 · with 19 other participants
£7,544,329
whole project
The Newcastle Upon Tyne Hospitals NHS Foundation TrustleadAlcyomics LimitedAsymptote LimitedAutolus LimitedCell Medica LimitedChiesi LimitedDatatrial LimitedHealth Innovation North East And North Cumbria LimitedLothian Health BoardMiltenyi Biotec LimitedNewcastle UniversityNHS Blood And TransplantNHS Greater Glasgow And ClydeRoslin Cell Therapies LimitedScottish National Blood Transfusion ServiceThe Leeds Teaching Hospitals NHS TrustThermo Electron LimitedTrakcel LimitedUniversity Of EdinburghWorld Courier Logistics (UK) Limited
Design, Transfer and Qualification of a Commercially-Scalable Manufacturing Process for CAR-T cellsLeadInnovate UK · Collaborative R&D · 2017-05-01 – 2019-10-31 · with 2 other participants£744,565awarded
Design, Transfer and Qualification of a Commercially-Scalable Manufacturing Process for CAR-T cellsLead
Innovate UK · Collaborative R&D · 2017-05-01 – 2019-10-31 · with 2 other participants
£744,565
awarded
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 89 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 89 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 89 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 89 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd
CAR Therapy for T Cell MalignanciesLeadInnovate UK · Collaborative R&D · 2016-05-01 – 2018-04-30 · with 1 other participant£1,151,331awarded
CAR Therapy for T Cell MalignanciesLead
Innovate UK · Collaborative R&D · 2016-05-01 – 2018-04-30 · with 1 other participant
£1,151,331
awarded
Autolus Limitedlead£1,151,331
Large scale lentiviral vector productionBBSRC · Research Grant · 2015-09-30 – 2018-09-29 · with 5 other participants£584,844whole project
Large scale lentiviral vector production
BBSRC · Research Grant · 2015-09-30 – 2018-09-29 · with 5 other participants
£584,844
whole project
King'S College LondonleadAutolus LimitedCellectisCell Therapy CatapultServier LaboratoriesUniversity of Lausanne
CAR therapy for Multiple MyelomaLead
Innovate UK · Collaborative R&D · 2015-04-01 – 2019-03-31
£1,482,960
awarded
BRIC: Packaging cell lines for inherently manufacturable viral vectorsBBSRC · Research Grant · 2007-03-31 – 2010-05-30 · with 4 other participants£251,318whole project
BRIC: Packaging cell lines for inherently manufacturable viral vectors
BBSRC · Research Grant · 2007-03-31 – 2010-05-30 · with 4 other participants
£251,318
whole project